Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03430843 |
|---|---|
| Brief Title: | A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma |
| First Submitted : | January 29, 2018 |
| First Submitted that Met QC Criteria : | February 6, 2018 |
| First Posted : | February 13, 2018 |
| Results First Submitted : | November 10, 2023 |
| Results First Posted with QC Comments : | December 6, 2023 |
| Results First Submitted that Met QC Criteria : | December 12, 2023 |
| Results First Posted : | December 29, 2023 |
| Certification/Extension First Submitted : | November 23, 2021 |
| Certification/Extension First Posted : | December 29, 2023 |
| Last Update Submitted that Met QC Criteria : | December 12, 2023 |
| Last Update Posted : | December 29, 2023 |